Search keyWord :

Porton Pharma Solutions and Aojin Life Sciences Announce Strategic Collaboration to Advance XDC Conjugate Drugs for Dual IND Filings in China and the U.S.

Dec 18, 2024

CHONGQING,China,Dec. 12,2024-- Recently,Porton Pharma Solutions Ltd. ("Porton") announced a strategic partnership with Aojin Life Sciences (Yixing) Co.,Ltd. ("Aojin Life Sciences")

SK bioscience Receives Approval for Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate

Dec 18, 2024

SK bioscience\'s first mRNA vaccine candidate is expected to enter clinical trials in Australia in February 2025,with interim results expected by 2026.

aiMotive collaborates with Sony Semiconductor Solutions to revolutionize AD simulations

Dec 18, 2024

BUDAPEST,Hungary,Dec. 12,2024--aiMotive,a leading developer of simulation and AI solutions for automated driving technology,in collaboration withSony Semiconductor Solutions Corporation (Sony),a glob

CureGene Received Clinical Trial Approval in China for CG-0255 for Injection - A Novel Antiplatelet Therapy

Dec 18, 2024

SHANGHAI,Dec. 12,2024-- CureGene Pharmaceutical ("CureGene"),a biotechnology company dedicated to innovative treatments for critical unmet medical needs in cardio-cerebrovascular and antivir

Xinhua Silk Road: Pien Tze Huang boosts TCM globalization

Dec 18, 2024

BEIJING,Dec. 12,2024-- Zhangzhou Pien Tze Huang Pharmaceutical Co.,Ltd.,a Fujian-based traditional Chinese medicine (TCM) company,has been striving to expand its overseas markets,enhancing the influen

Xinhua Silk Road: Exploring charm of intangible cultural heritage in Minhang District of Shanghai

Dec 18, 2024

BEIJING,Dec. 12,2024--The city of Shanghai is a first choice for many foreign tourists to learn about China. Join us in a video tour to Minhang District in Shanghai and explore the charm of intangible

2024 SABCS|Results Unveiled for the Phase III Study of Disitamab Vedotin in Treating HER2-Positive Advanced Breast Cancer with Liver Metastasis

Dec 18, 2024

YANTAI,China,Dec. 13,2024-- On the morning of December 12,2024 (UTC-6),at the Poster Spotlight Session "Novel HER2 Therapeutics" of the 47th San Antonio Breast Cancer Symposium (SABCS),Reme

Lichen China Limited Announces $2.70 Million Registered Direct Offering

Dec 18, 2024

XIAMEN,China,Dec. 13,2024--Lichen China Limited (Nasdaq: LICN)("Lichen China" or the "Company"),a dedicated financial and taxation service provider inChina today announced that it

IBM and State of Illinois to Build National Quantum Algorithm Center in Chicago with Universities and Industries

Dec 18, 2024

Anchored by next-generation IBM Quantum System Two in Illinois Quantum and Microelectronics Park,new initiative will advance useful quantum applications as industries move towards quantum-centric supe

HUAWEI MatePad 11.5 Embraces Paperless Productivity with Ease

Dec 18, 2024

DUBAI,UAE,Dec. 13,2024--The next generation of HUAWEI MatePad 11.5 was unveiled at HUAWEI Product Launch,hosted at Atlantis The Royal\'s Diamond Ballroom inDubai.

1 ... 587 588 589 590 591 592 593 ... 1285